EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,866,000 | +5.0% | 42,911 | +20.9% | 0.01% | 0.0% |
| Q3 2021 | $1,777,000 | -24.3% | 35,502 | -4.7% | 0.01% | -36.4% |
| Q2 2021 | $2,347,000 | -54.9% | 37,259 | -33.5% | 0.01% | -59.3% |
| Q1 2021 | $5,202,000 | -11.5% | 55,998 | -14.7% | 0.03% | -20.6% |
| Q4 2020 | $5,881,000 | +44.0% | 65,629 | +66.0% | 0.03% | +30.8% |
| Q3 2020 | $4,085,000 | +25.6% | 39,532 | -3.9% | 0.03% | +18.2% |
| Q2 2020 | $3,252,000 | +6.9% | 41,121 | -21.8% | 0.02% | -12.0% |
| Q1 2020 | $3,042,000 | +81.7% | 52,574 | +69.4% | 0.02% | +108.3% |
| Q4 2019 | $1,674,000 | -35.6% | 31,036 | -37.6% | 0.01% | -42.9% |
| Q3 2019 | $2,599,000 | +21.8% | 49,727 | +12.6% | 0.02% | +23.5% |
| Q2 2019 | $2,133,000 | +10.3% | 44,150 | +15.3% | 0.02% | 0.0% |
| Q1 2019 | $1,933,000 | – | 38,276 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
| Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
| SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
| Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
| Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
| BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
| EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
| DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |